1. Home
  2. EXYN vs COCP Comparison

EXYN vs COCP Comparison

Compare EXYN & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exyn Technologies Inc. Common Stock

EXYN

Exyn Technologies Inc. Common Stock

HOLD

Current Price

$2.96

Market Cap

21.2M

Sector

N/A

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$0.96

Market Cap

21.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXYN
COCP
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
21.6M
IPO Year
2026
2011

Fundamental Metrics

Financial Performance
Metric
EXYN
COCP
Price
$2.96
$0.96
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $8.00
AVG Volume (30 Days)
★ 1.2M
41.6K
Earning Date
11-19-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 54.65
EPS
N/A
★ N/A
Revenue
N/A
★ $12,712,091.00
Revenue This Year
$29.76
N/A
Revenue Next Year
$32.94
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.76
52 Week High
$6.98
$2.03

Technical Indicators

Market Signals
Indicator
EXYN
COCP
Relative Strength Index (RSI) 60.00 28.35
Support Level $2.26 $0.86
Resistance Level $2.98 $1.11
Average True Range (ATR) 0.36 0.05
MACD 0.08 -0.02
Stochastic Oscillator 72.73 13.33

Price Performance

Historical Comparison
EXYN
COCP

About EXYN Exyn Technologies Inc. Common Stock

Exyn Technologies Inc is a pioneer in fully adaptive, cognitive mission-level autonomous robotics and artificial intelligence, delivering solutions that enable safe, efficient, and scalable autonomy in complex, GPS-denied environments. Its mission is to deliver world-class autonomous robots to data-hungry industries, unlocking new insights that drive smarter decisions. The group is leveraging proprietary Level 4B autonomy software and cutting-edge aerial and ground robotic systems. It empowers industries, including mining, construction, critical infrastructure, and defense, with real-time 3D mapping, data analytics, and autonomous navigation. Its software and hardware include ExynAI, ExynAI SDK, ExynView, Nexys, Accessories, and Platforms.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Share on Social Networks: